German firm Syntellix opens first overseas facility in Singapore
The orthopaedic implant maker projects that overall investment will reach S$200 million by 2024, with a potential cumulative revenue of S$500 million by then
Singapore
SYNTELLIX, a German firm that pioneered the use of bioabsorbable bone implants, opened its first overseas production site in Singapore on Tuesday, amid expectations of strong growth in the medical technology industry in this region.
While initial investment in the facility falls within an undisclosed "single-digit" million dollars, Syntellix founder, CEO and executive chairman Utz Claassen projected overall investment to reach S$200 million by 2024, with a potential cumulative revenue of S$500 million by then.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Indian central bank issues draft guidelines for web aggregators of loan products
Vietnam National Assembly head resigns amid graft purge
China central bank flags bond investment risks to some financial institutions: sources
Xi tells Blinken US, China should be 'partners, not rivals'
Indonesia’s push for regional economic integration to continue under Prabowo: Vivian Balakrishnan
Outgoing Singapore, Indonesia leaders to hold their final retreat in Bogor on Apr 29